SAFETY AND CLINICAL EFFICACY IN BIOSIMILAR SUBSTITUTION
Biosimilar medicinal products have become a reality in recent years. Despite an established legal pathway for biosimilars in the European Union since 2005 and increasing regulatory guidance on data requirements for their development and approval, many clinicians are still reluctant to consider biosi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Formifarma, LDA.
2015-01-01
|
| Series: | Revista Portuguesa de Farmacoterapia |
| Subjects: | |
| Online Access: | http://revista.farmacoterapia.pt/index.php/rpf/article/view/15 |